Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 96INDUSTRY 40NIH 21OTHER_GOV 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Colorectal Neoplasms 13Neoplasms 11Breast Neoplasms 11Carcinoma, Hepatocellular 10Prostatic Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Stomach Neoplasms 5Lung Neoplasms 5Anastomotic Leak 5Uterine Cervical Neoplasms 4Rectal Neoplasms 4Ovarian Neoplasms 4Lymphoma, Follicular 4Stomatitis 3Pancreatic Neoplasms 3Multiple Myeloma 3HIV Infections 3Disease 3Depression 3Vulvar Neoplasms 2Surgical Wound Infection 2Sleep Initiation and Maintenance Disorders 2Skin Neoplasms 2Sarcoma 2Postoperative Complications 2Peritoneal Neoplasms 2Neuroendocrine Tumors 2Neoplasms, Plasma Cell 2Neoplasm Metastasis 2Motor Activity 2

Interventions

defactinib 1decitabine and cedazuridine drug combination 1cedazuridine 1Decitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Myelodysplastic Syndromes × 90 days × Clear all
NCT05636514 2026-03-18

CELESTIAL-MDS

Clinical Hub for Interventional Research (CHOIR)

Phase 1 Recruiting
12 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡